72721-02-9

Basic information

• Product Name: 5,6-Dimethoxybenzimidazole
• Synonyms: 5,6-DIMETHOXYBENZIMIDAZOLE;1H-Benzimidazole,5,6-dimethoxy-(9CI);5,6-dimethoxy-1H-benzo[d]imidazole;5,6-Dimethoxy-1H-benzimidazole;5,6-diMethoxy-1H-1,3-benzodiazole;1H-BenziMidazole, 5,6-diMethoxy-
• CAS NO: 72721-02-9
• Molecular Formula: C₉H₁₀N₂O₂
• Molecular Weight: 178.19
• EINECS: -0
• Product Categories: BENZIMIDAZOLE;Imidazol&Benzimidazole
• Mol File: 72721-02-9.mol

Chemical Properties

• Melting Point: 183-189°C
• Boiling Point: 398.6 °C at 760 mmHg
• Flash Point: 144.6 °C
• Appearance: /
• Density: 1.245 g/cm³
• PKA: 13.46±0.30(Predicted)
• CAS DataBase Reference: 5,6-Dimethoxybenzimidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5,6-Dimethoxybenzimidazole(72721-02-9)
• EPA Substance Registry System: 5,6-Dimethoxybenzimidazole(72721-02-9)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 72721-02-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5,6-Dimethoxybenzimidazole is used as a key intermediate in the synthesis of various drugs, contributing to their development and effectiveness in treating different medical conditions. Its specific chemical structure allows for the creation of new drug molecules with potential therapeutic benefits.
Safety Considerations:
While 5,6-Dimethoxybenzimidazole is a useful compound in pharmaceutical applications, it is important to handle it with care due to its potential to cause eye or skin irritation. Additionally, it may have harmful effects if absorbed into the body, so appropriate protective measures should be taken during its use and production.

Upstream product

• 64-18-6 formic acid 
• 131076-14-7 4,5-dimethoxy-1,2-phenylenediamine hydrochloride salt 
• 3395-03-7 4,5-dimethoxy-1,2-dinitrobenzene 
• 91-16-7 1,2-dimethoxybenzene 
• 27841-33-4 4,5-dimethoxybenzene-1,2-diamine 
• 88580-71-6 1,2-diamino-4,5-dimethoxybenzene monohydrochloride 

Downstream Products

• 102169-73-3 5,6-Dihydroxybenzimidazole 
• 5118-06-9 methyl 3-hydroxy-2-thiophenecarboxylate 
• 4701-07-9 5,6-dimethoxy-1-methylbenzimidazole 

Relevant articles and documents

Efficient N-Heterocyclic Carbene/Ruthenium Catalytic Systems for the Alcohol Amidation with Amines: Involvement of Poly-Carbene Complexes?

The atom-economic direct amidation of alcohols with amines has been recently highlighted as an attractive and promising transformation. Among the versatile reported catalytic systems, in situ generated N-heterocyclic carbene (NHC)/ruthenium (Ru) catalytic systems have demonstrated their advantages such as easy operation and use of commercial Ru compounds. However, the existing catalyst loadings are relatively high, and additional insights for the in situ catalyst generation are still not well-documented. In this work, a variety of benzimidazole-based NHC precursors were initially synthesized. Through the screening of various NHC precursors and other reaction conditions, active in situ catalytic systems were discovered for the efficient amide synthesis. Notably, the catalyst loading is as low as 0.5 mol %. Furthermore, additional experiments were performed to validate the rationale for the superiority of the current catalytic systems over our previous system. It was observed that the ligand structure is one of the reasons for the higher activity. In addition, the higher ratio of the NHC precursor/[Ru] is another important factor for the improvement. Further HR-MS analysis identified the formation of two mono-NHC-Ru species as major species and two Ru species bearing multiple NHC ligands as minor species. Hopefully, the efficient and readily-accessible catalytic systems reported herein could demonstrate great potential for further practical applications.

Expanding the aqueous-based redox-facilitated self-polymerization chemistry of catecholamines to 5,6-dihydroxy-1H-benzimidazole and its 2-substituted derivatives

Aqueous-base redox-facilitated self-polymerization can be performed with 5,6-dihydroxy-1H-benzimidazole (DHBI) to generate polymeric material that is analogous to poly(dopamine) (PDA), proving the possibility to expand the catecholamine-exclusive chemistr

7-Substituted Purine Derivatives for Immunosuppression

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula III:

7-SUBSTITUTED PURINE DERIVATIVES FOR IMMUNOSUPPRESSION

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula (III).

Thiazolyl-benzimidazoles

The invention is directed to compounds of formula (1) [image] and pharmaceutically acceptable salts thereof, methods for the preparation thereof, and methods of use thereof.

PURINE AND IMIDAZOPYRIDINE DERIVATIVES FOR IMMUNOSUPPRESSION

The present invention provides novel purine and imidazopyridine derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formulas ( I ) and ( II ).